Lyra Therapeutics Quote - LYRA

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.1806

Bid

0.179

Offer

0.1827

Volume

327,319

0.1752 Day's Range 0.187

0.1625 52 Week Range 6.79

Market Cap

11.822M

Previous Close

0.1869

Open

0.187

Last Trade

0.181

Last Trade Time

02:33:04

Financial Volume

US$ 58,762

VWAP

0.179526

Average Volume (3m)

1,915,094

Shares Outstanding

65,457,648

Dividend Yield

PE Ratio

-0.19

Earnings Per Share (EPS)

-0.96

Revenue

1.56M

Net Profit

-62.68M

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

lyratherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was US$0.19. Over the last year, Lyra Therapeutics shares have traded in a share price range of US$ 0.1625 to US$ 6.79.

Lyra Therapeutics currently has 65,457,648 shares in issue. The market capitalisation of Lyra Therapeutics is US$12.23 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.19.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0134	-6.90721649485	0.194	0.201051	0.1752	592682	0.1901766	CS
4	-0.0564	-23.7974683544	0.237	0.237	0.1752	1442276	0.20285093	CS
12	-0.0874	-32.6119402985	0.268	0.28	0.1625	1915094	0.19720629	CS
26	-0.1231	-40.5334211393	0.3037	0.344	0.1625	1417524	0.23141535	CS
52	-4.5994	-96.2217573222	4.78	6.79	0.1625	1791494	0.63966688	CS
156	-3.3594	-94.8983050847	3.54	8.18	0.1625	691849	1.1602686	CS
260	-20.8194	-99.14	21	22	0.1625	470142	1.91598449	CS

LYRA - Frequently Asked Questions (FAQ)

What is the current Lyra Therapeutics share price?

The current share price of Lyra Therapeutics is US$ 0.1806

How many Lyra Therapeutics shares are in issue?

Lyra Therapeutics has 65,457,648 shares in issue

What is the market cap of Lyra Therapeutics?

The market capitalisation of Lyra Therapeutics is USD 12.23M

What is the 1 year trading range for Lyra Therapeutics share price?

Lyra Therapeutics has traded in the range of US$ 0.1625 to US$ 6.79 during the past year

What is the PE ratio of Lyra Therapeutics?

The price to earnings ratio of Lyra Therapeutics is -0.19

What is the cash to sales ratio of Lyra Therapeutics?

The cash to sales ratio of Lyra Therapeutics is 7.56

What is the reporting currency for Lyra Therapeutics?

Lyra Therapeutics reports financial results in USD

What is the latest annual turnover for Lyra Therapeutics?

The latest annual turnover of Lyra Therapeutics is USD 1.56M

What is the latest annual profit for Lyra Therapeutics?

The latest annual profit of Lyra Therapeutics is USD -62.68M

What is the registered address of Lyra Therapeutics?

The registered address for Lyra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Lyra Therapeutics website address?

The website address for Lyra Therapeutics is lyratherapeutics.com

Which industry sector does Lyra Therapeutics operate in?

Lyra Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Symbol	Price	Vol.
SLXNSilexion Therapeutics Corporation	US$ 1.22 (110.34%)	139.26M
YIBOPlanet Image International Ltd	US$ 4.9808 (61.71%)	42.66M
TRIBTrinity Biotech PLC	US$ 1.20 (57.89%)	90.99M
HEPAHepion Pharmaceuticals Inc	US$ 0.2478 (50.18%)	169.73M
RNAZTransCode Therapeutics Inc	US$ 10.054 (47.20%)	5.49M
LPTXLeap Therapeutics Inc	US$ 0.655 (-70.89%)	5.62M
STSSSharps Technology Inc	US$ 0.4585 (-68.60%)	8.73M
SABSSAB Biotherapeutics Inc	US$ 2.15 (-50.69%)	676.27k
MGOLMGO Global Inc	US$ 0.172 (-39.22%)	10.59M
JGAurora Mobile Ltd	US$ 10.21 (-29.73%)	1.26M
HEPAHepion Pharmaceuticals Inc	US$ 0.2481 (50.36%)	169.73M
NVDANVIDIA Corporation	US$ 121.00 (2.18%)	159.51M
SLXNSilexion Therapeutics Corporation	US$ 1.22 (110.34%)	139.26M
TRIBTrinity Biotech PLC	US$ 1.20 (57.89%)	91M
BACKIMAC Holdings Inc	US$ 1.095 (32.09%)	50.03M

Symbol

Price

Vol.